Medically Reviewed by Dr. Lisa Hartford, MD
Red Light Therapy During Pregnancy and Postpartum: The Evidence-Based Safety, Wavelength, and Recovery Guide
Eight things to know about red light therapy in pregnancy
- Fact 01Red light at 630nm and near-infrared at 850nm are non-ionizing, do not damage DNA, and cannot reach the developing fetus through maternal facial skin.
- Fact 02No published clinical study has documented harm from cosmetic red light therapy or LED face mask use during pregnancy.
- Fact 03The Mirage Pro's M1 Repair mode emits only 630nm red light and is the cleanest pregnancy-aligned LED face mask setting.
- Fact 04Blue light at 415nm should be avoided during pregnancy due to limited safety data and a theoretical melasma-aggravation risk in melasma-prone skin.
- Fact 05Postpartum red light therapy has randomized controlled trial evidence for perineal trauma recovery, nipple healing, and C-section pain management.
- Fact 06Melasma affects 50 to 70 percent of pregnancies. Broad-spectrum mineral SPF 50+ reduces incidence from 53 percent to 2.7 percent (Lakhdar 2007).
- Fact 07The FDA has not cleared any cosmetic LED device specifically for pregnancy use, which reflects clinical trial exclusion of pregnant women rather than evidence of harm.
- Fact 08The LactMed database lists light-based therapies including photobiomodulation as compatible with breastfeeding when used away from the active feeding zone.
The 30-second verdict on LED light therapy during pregnancy
The honest answer most brands won't give you: red light therapy at 630nm and near-infrared at 850nm appear to be among the safer cosmetic-skincare options during pregnancy, but the evidence is built on indirect data, animal models, postpartum trials, and decades of dermatology research rather than pregnancy-specific randomized controlled trials. That nuance matters. Anyone who tells you red light therapy is definitely safe in pregnancy is overselling. Anyone who tells you to avoid LED face masks entirely is underselling. The truthful position sits between those two.
What this guide gives pregnant readers, that "ask your doctor" articles don't, is the specific wavelength-by-wavelength, mode-by-mode breakdown. Not all "red light" is the same. The Mirage Pro, our new four-wavelength LED mask, emits 415nm blue, 590nm yellow, 630nm red, and 850nm/1072nm near-infrared. Two of those wavelengths are well-suited to pregnancy with OB clearance. Two of them aren't. Knowing which is which is the entire point of this article.
What this LED pregnancy guide covers
This guide is for you if
Ideal Reader
- You're pregnant or planning, and want skin support that doesn't require retinol or Botox pauses
- You're postpartum, managing melasma, hair shedding, or scar recovery
- You already own an LED face mask and want to know what's safe to keep using
- You want sourced answers, not blanket "consult your doctor" deflections
You can skip this if
- You want in-clinic procedures like Botox, fillers, lasers, or peels during pregnancy
- You're considering RF, microcurrent, or ultrasound during pregnancy (different article, different verdict)
- You want a one-line yes-or-no without clinical context
- You haven't yet spoken to your OB about cosmetic device use
Can pregnant women use red light therapy? Generally yes, with conditions. Red light at 630nm and near-infrared at 850nm have not been shown to harm pregnancy or fetal development in any published clinical study, and have been used postpartum in randomized controlled trials for wound healing, perineal trauma, and nipple-trauma recovery with positive results. Pregnancy-specific RCTs don't exist because pregnant women are excluded from cosmetic-device trials on ethical grounds, so confidence is built from mechanism (non-ionizing, non-mutagenic light), tissue depth (LED photons penetrate at most 5mm and cannot reach a developing fetus through maternal abdominal tissue), and adjacent postpartum evidence.
The practical protocol: Use red light therapy on the face, neck, and limbs only, with OB clearance, with sessions limited to the device's preset 10 minutes. Avoid the abdomen, breasts, and pelvis throughout pregnancy. Skip blue light (415nm) modes until postpartum. Defer the first trimester if you can. Postpartum and breastfeeding open up more body zones and modes once your OB has cleared you, including breast-area use for nipple-trauma recovery and abdominal use for C-section scar support.
When "ask your doctor" stops being an answer about red light therapy
Pregnancy is the period when most women stop touching their skincare routine entirely. Retinol is out. Salicylic acid over 2 percent is out. Hydroquinone is out. Most chemical peels are out. The list of things you used to do that you can't do for the next nine to twelve months is long, well-publicised, and unambiguous.
The list of things you can do is short and largely unhelpful. Sunscreen, gentle cleansers, vitamin C if your dermatologist says it's fine, hyaluronic acid, niacinamide, azelaic acid in the right concentration. None of those address the actual skin changes pregnancy brings: the melasma that appears on your cheeks around month four, the hormonal acne that suddenly looks like teenage acne, the skin texture changes from progesterone shifts, the dullness that has nothing to do with sleep. Pregnant women aren't asking whether they should worry about skincare. They're asking what they're allowed to do.
Red light therapy and LED face mask use sit in a strange position in this conversation. Photobiomodulation has been used in obstetric clinical practice for perineal trauma, nipple cracks, and postpartum pain management.89 Low-level light therapy has been studied for over four decades as a treatment for everything from oral mucositis in chemotherapy patients to wound healing in diabetic ulcers.1 The mechanism is well-characterized, the safety profile in non-pregnant adults is excellent, and the technology is now sold in handheld masks for under $300.
And yet, ask any LED brand whether it's safe to use red light therapy during pregnancy and the answer is almost always the same sentence: "Consult your healthcare provider." Ask your OB-GYN the same question and the answer is often a slightly longer version of "I don't know, the research isn't there." Both responses are technically correct. Neither one helps you decide whether to put your LED mask in the donation box for nine months or keep using it.
This article is the version that gives you what those answers don't. We've broken the question apart into the four wavelengths actually emitted by modern multi-spectrum LED devices like the Mirage and the new Mirage Pro. We've looked at where each wavelength penetrates, what evidence exists for each, and what the clinical reasoning is for using or avoiding each one during pregnancy. The conclusions aren't all the same. The right answer depends on which light, which mode, which body zone, and which trimester.
"Red light" is not one thing. The wavelength-by-wavelength answer is the only answer worth giving.
Four ways the standard "is red light therapy safe in pregnancy" answer fails you
Before getting to mechanism, protocol, and Dr. Kimji's clinical position, it helps to understand why the conversation around LED therapy in pregnancy is so muddled. Four specific failure modes appear across nearly every source you'll find online or hear in a clinic.
Treating all "red light" as one thing
Most LED masks emit four to five distinct wavelengths. Blue at 415nm, yellow at 590nm, red at 630nm or 660nm, and near-infrared at 830nm, 850nm, or 1072nm. Each wavelength has a different absorption profile, penetrates to a different depth, and acts on different cellular chromophores. Lumping them together as "red light" and asking whether "red light" is safe in pregnancy is like asking whether "food" is safe in pregnancy. The question is ill-formed.
Confusing absence of evidence with evidence of risk
Pregnant women are excluded from cosmetic-device clinical trials on ethical grounds. Any device a sponsor takes through FDA clearance will carry a pregnancy disclaimer because the sponsor cannot prove safety without a trial. The disclaimer reflects regulatory caution, not a clinical finding of harm. There is no published case of red or near-infrared LED light causing adverse pregnancy outcomes anywhere in the medical literature.7
Treating the abdomen the same as the face
A 10-minute LED facial session and direct prolonged exposure of the developing uterus are different propositions. Photobiomodulation light penetrates a few millimetres at most into tissue. A face mask aimed at facial skin does not deliver therapeutic doses to the fetus. Anatomy and distance matter. Sensible guidance differentiates by body zone, not by "is the device on or off."
Conflating LED therapy with laser and UV
Salons advertise "light therapy" services that include UV-based phototherapy for psoriasis, laser hair removal, and IPL pigmentation treatment. Those are different categories of technology with different pregnancy guidance. LED photobiomodulation is non-ionizing, doesn't generate UV, and operates at energy densities far below ablative or hair-removal lasers. The pregnancy guidance for one doesn't transfer to the other.
Why a single yes-or-no answer about LED in pregnancy can't exist
If you've made it this far, you might be expecting a clean answer that doesn't require sorting through four wavelengths and three trimesters. There isn't one, and any source giving you a clean answer is collapsing too many variables into a single sentence.
Wavelength selectivity
Each wavelength has a clinical profile. Red at 630nm is the most-studied LED wavelength for cosmetic facial use, with the strongest safety record and the most evidence for collagen and fibroblast support. Near-infrared at 850nm penetrates deeper but still does not reach beyond about 5mm of tissue. Blue at 415nm targets sebaceous bacteria but has limited pregnancy data and a theoretical concern around visible-light melasma. Yellow at 590nm sits in between.
Body zone
Facial skin, neck, chest, abdomen, breast tissue, perineum, and limbs each carry different considerations. The abdomen in pregnancy is the area of clearest caution, regardless of wavelength. The face during pregnancy is the area of clearest evidence base, given how often LED facial treatments are performed in dermatology offices. Postpartum, the breast and perineum become relevant zones with their own randomized-trial evidence base.810
Trimester
First trimester is the period of organogenesis and the period of highest theoretical sensitivity to any external intervention. Most clinicians recommend deferring elective cosmetic interventions during this window, even ones with good safety profiles, simply because the cost of being wrong is highest here. Second and third trimester evidence is generally more permissive, particularly for facial-only LED face mask treatments.
Dose and duration
Photobiomodulation has a biphasic dose response. Low doses stimulate cellular activity, high doses inhibit it.1 Most consumer LED face masks operate at the low-stimulation end of the range, often 30 to 60 mW/cm squared with 10-minute sessions delivering 18 to 36 J/cm squared total fluence. This is well below the dose at which any adverse cellular effects have been documented even in non-pregnant populations.
How red light therapy actually works at the cellular level
Photobiomodulation, the formal name for what consumer brands market as "red light therapy" or "LED light therapy," is a non-thermal, non-ionizing biological response triggered when red or near-infrared photons are absorbed by specific chromophores inside cells. The primary chromophore is cytochrome c oxidase, an enzyme in the inner mitochondrial membrane responsible for the final step of the electron transport chain.13 When photons in the 600nm to 1000nm range are absorbed by cytochrome c oxidase, several downstream effects follow: a transient increase in ATP production, a brief burst of reactive oxygen species at signalling levels, a release of nitric oxide, and modulation of intracellular calcium.
The cascade of secondary effects matters because it's the mechanism through which LED light promotes collagen synthesis, reduces inflammation, and accelerates wound healing. Studies on human fibroblasts have shown that 640nm red and 830nm near-infrared LED light at low fluences upregulate hyaluronic acid synthase and elastin gene expression within three days of treatment.5 Randomized split-face trials at 633nm and 830nm have shown reductions in wrinkle depth and increases in collagen density after 8 to 12 weeks of consistent treatment.46
Where each LED wavelength reaches in skin
415nm blue light: surface only, around 1mm depth, targets sebaceous glands and Cutibacterium acnes bacteria. 590nm yellow: 1 to 2mm into papillary dermis. 630nm red: 2 to 3mm, reaching mid-dermis where fibroblasts live. 850nm and 1072nm near-infrared: 3 to 5mm, reaching reticular dermis and superficial subcutaneous tissue.17 None of these wavelengths reach a developing fetus through maternal abdominal tissue.
Non-ionizing electromagnetic radiation
Red and near-infrared light is non-ionizing. It cannot break chemical bonds, cannot damage DNA directly, and cannot cause the mutagenic effects associated with UV-B, UV-C, X-rays, or gamma radiation. This is the same category as visible light, radio waves, and Wi-Fi. The biological effects are mediated through chromophore absorption and downstream signalling, not through ionization.1
The cancer-safety question
A 2023 systematic review of the oncologic safety of LLLT for aesthetic skin rejuvenation concluded that within established treatment parameters, red and near-infrared light enhances proliferation of healthy cells without a clear pattern of effect on cell viability, while neoplastic cells generally show reduced proliferation or no change. The review found no clinical trial data linking PBM with new or recurrent malignancy.7 Relevant to pregnancy because rapid cell proliferation is involved, and the absence of pro-tumourigenic signal is reassuring.
The biphasic response
PBM has a U-shaped dose curve. Doses in the 1 to 10 J/cm squared range tend to stimulate desired cellular responses. Doses above approximately 30 J/cm squared per session may cause inhibition or photobiomodulation paradoxical effects. Consumer LED face masks are calibrated to the stimulation range. The Mirage Pro at 48 to 60 mW/cm squared over a 10-minute session delivers approximately 28.8 to 36 J/cm squared, sitting at the upper-stimulation portion of the curve.
Wavelength-by-wavelength: which LED colors are safe during pregnancy?
The mode and wavelength conversation matters more than the brand conversation. Below is what the evidence says, color by color, for the four LED wavelengths most commonly emitted by consumer devices including the Mirage and the Mirage Pro.
630nm Red Light
Pregnancy-appropriateThe most-studied wavelength in cosmetic LED literature. Penetrates 2 to 3mm to fibroblast layer. Stimulates collagen production and cellular regeneration. No documented pregnancy harm. Default-recommended for facial use during the second and third trimester with OB clearance. The Mirage Pro M1 Repair mode uses this wavelength exclusively.
850nm and 1072nm Near-Infrared
Pregnancy-appropriateDeeper-penetrating NIR wavelengths reaching 3 to 5mm. Stronger evidence for dermal remodelling and tissue repair. Used in published postpartum trials for perineal trauma and wound healing.8 Combined with 630nm red in the Mirage Pro M3 Anti-aging mode. Same conservative-zone restrictions apply: face, neck, limbs only during pregnancy.
590nm Yellow Light
Use with cautionTargets superficial vascular changes and pigmentation. Less pregnancy-specific data than 630nm red, no known harm signal but evidence base is thinner. Present in Mirage Pro M2 Rejuvenation and M4 Morning modes. If your dermatologist has cleared yellow specifically, fine. Otherwise prefer the cleaner red-only or red-plus-NIR modes during pregnancy.
415nm Blue Light
Defer to postpartumTargets acne-causing bacteria. Limited pregnancy-specific data, and emerging dermatology evidence that visible light in the violet-blue range can stimulate melanogenesis in melasma-prone skin. Pregnancy is the prototype melasma-prone state. Active in Mirage Pro M5 Anti-acne, M4 Morning, and M6 Bedtime modes. Save for postpartum, when blue light becomes useful again for postpartum hormonal acne management.
"The question I get from pregnant patients is not 'is red light therapy safe' but 'is there any reason to think it isn't.' Those are different questions, and the answers are different. On reasonable mechanistic grounds, red and near-infrared LED light is one of the lowest-risk cosmetic interventions available to a pregnant patient. It's non-ionizing, non-mutagenic, doesn't reach systemic circulation, doesn't penetrate to the fetus from facial treatment, and has been used postpartum in obstetric settings without reported harm."
"That said, I tell my patients three things. First, defer the first trimester if you can, simply because that's the period where any external intervention carries the highest theoretical cost of being wrong. Second, avoid the abdomen and direct breast exposure during pregnancy, not because the light reaches the fetus, but because there's no upside in the face, neck, and limbs that you can't achieve without those zones. Third, skip blue light, the 415nm wavelength, until postpartum. The data is thinner there and the indications, mostly acne, can usually be managed differently during pregnancy."
Royal College of Physicians and Surgeons of Canada
Doctor in Residence, Evenskyn
The Mirage Pro LED face mask: mode-by-mode breakdown for pregnancy
Evenskyn's LED line gives the pregnancy conversation an unusual amount of nuance because it includes two different products with very different spectral profiles. The original Mirage is a red-and-near-infrared-only device, simpler in construction and easier to reason about during pregnancy. The new Mirage Pro is a four-wavelength multi-spectrum device, with the spectral range that lets you do more, but with more decisions to make about which mode to use when.
The Mirage Pro is built around 360 individual LEDs arranged in a contoured, food-grade silicone mask that wraps the face. The wavelengths are split equally across blue at 415 nanometres, yellow at 590 nanometres, red at 630 nanometres, and near-infrared at 850 to 1072 nanometres, in a one-to-one-to-one-to-one ratio. The battery runs 4,000mAh. The timer is fixed at 10 minutes per session. The irradiance sits between 48 and 60 mW/cm squared at the LED face. There's a three-level dimming control at 100, 75, and 50 percent. The pulse function operates at 10 Hz. The mask comes in pink food-grade silicone, intentionally close to skin so that no fabric or padding sits between the LED and the face.
What matters for pregnancy is the mode structure. The Mirage Pro ships with six pre-set modes. Two of them are pregnancy-appropriate with OB clearance. One is partially appropriate. Three contain wavelengths we recommend deferring until postpartum.
Mode-by-mode breakdown for pregnant readers
630nm red only: pregnancy-appropriate
The single-wavelength red mode. This is the cleanest pregnancy use case on the device. Red at 630nm is the most-studied LED wavelength for cosmetic facial use, with the strongest safety record and the most evidence for collagen and fibroblast support.45 No blue, no yellow, no NIR overlap. Use this mode for facial treatment during the second and third trimester with OB clearance.
630nm + 850nm + 1072nm: pregnancy-appropriate
Red plus near-infrared, no blue, no yellow. This is the strongest mode for collagen, elasticity, and dermal remodelling, and it's the mode most aligned with the published clinical evidence on LED photoaging treatment.616 The NIR adds depth to the treatment without bringing in the wavelengths with weaker pregnancy data. Recommended mode for facial use during second and third trimester with clearance.
590nm + 630nm: use with caution
Adds yellow to the red. Yellow at 590nm has less pregnancy-specific data than 630nm red, though no known harm signal. If you're comfortable being conservative, prefer M1 or M3 instead. If your dermatologist or OB has cleared yellow specifically, M2 is fine for facial use.
All four wavelengths: defer to postpartum
The full-spectrum mode. Includes blue, which we recommend skipping during pregnancy. Save this mode for postpartum, when the indication set widens and blue's anti-acne profile becomes useful again for postpartum hormonal acne.
415nm blue only: defer to postpartum
The dedicated blue light mode. Pregnancy data on 415nm exposure is sparse, and there's a theoretical concern around visible-light induced melasma in already pigmentation-prone pregnant skin. The clinical indication for this mode, hormonal acne, can usually be managed with pregnancy-safe topicals like azelaic acid until postpartum. Skip until cleared.
Sequenced multi-mode: defer to postpartum
Cycles through 590nm, then 630/850/1072nm, then 415nm. The blue endpoint puts this mode in the same category as M4 and M5. Use postpartum when the full mode library opens back up.
The simpler original Mirage mask is the easier device to reason about during pregnancy, because it has fewer wavelengths and fewer decisions. The Mirage Pro is the more capable device for the full skin lifecycle, with the caveat that you'll only use a subset of its modes during the pregnancy window itself.
The deciding factor that puts LED in a different category from other devices
If you sit through the literature on cosmetic interventions during pregnancy, the single line that recurs across reviews is some version of: "if the mechanism cannot biologically reach the fetus, the safety threshold is much lower than for interventions that can." That line is the entire structure of how OB-GYNs and dermatologists evaluate cosmetic procedures in pregnant patients. It's why topical vitamin C is fine and oral isotretinoin is contraindicated. It's why nail polish is fine and chemical peels with high systemic absorption aren't.
LED red light therapy sits firmly in the "cannot biologically reach the fetus" category. Photons in the 415 to 1072 nanometre range penetrate a few millimetres of tissue at most and don't enter systemic circulation in any meaningful sense. Light absorbed by maternal facial skin doesn't reach the developing fetus, doesn't cross the placenta, and doesn't have downstream metabolites the way a topical medication might. The cellular signalling effects of photobiomodulation are local to the irradiated tissue.
This is the mechanistic reasoning underneath the pragmatic guidance to use red and near-infrared LED on the face, neck, and limbs but to avoid direct treatment of the abdomen during pregnancy. The avoidance isn't because anything happens when light hits the abdomen. It's that the cost-benefit ratio of treating that zone during pregnancy is unfavourable when there's no specific clinical indication. You get the cosmetic benefit elsewhere.
Most LED brands, including Evenskyn, will not give you the wavelength-by-wavelength, mode-by-mode breakdown you just read. Brands are legally exposed when they recommend any specific use case during pregnancy, because there's no FDA clearance for pregnancy use of cosmetic LED devices. The disclaimer language across the category exists for legal reasons, not because brands have private clinical evidence of risk. This article is the closest version we can publish to "what we'd tell a friend who asked." Take it as that. Talk to your OB. Decide for yourself.
Trimester-by-trimester LED protocol: four reader profiles
Pregnancy isn't a single nine-month state. The first trimester, the second and third, the immediate postpartum period, and the breastfeeding-and-beyond stretch each carry distinct clinical considerations. Most LED-in-pregnancy content online flattens this into a single answer. Below is the version that doesn't.
First trimester (weeks 1 to 13)
Skin context: Hormonal acne kicking in. Melasma rarely visible yet. Skin sensitivity heightened from progesterone surge.
Our position: Defer cosmetic LED use entirely if you can. The window of organogenesis is the period of highest theoretical sensitivity to any external intervention. The cosmetic benefit is small. The downside of being wrong is uniquely high. If you're already mid-routine and stopping feels like over-correction, M1 Repair on the face only is a reasonable continuation, briefly, until you can talk to your OB.
Second and third trimester (weeks 14 to 40)
Skin context: Melasma starting on cheeks, upper lip, forehead in roughly 50 to 70 percent of pregnancies.14 Hormonal acne plateauing or shifting. Skin barrier sometimes more fragile.
Our position: M1 Repair and M3 Anti-aging on the face, neck, and limbs, with OB clearance, sessions kept to the device's pre-set 10 minutes, two to four times per week. Avoid the abdomen, breasts, and pelvis. Pair with strict broad-spectrum SPF 50+ for melasma prevention.
Immediate postpartum (0 to 8 weeks)
Skin context: Postpartum melasma may persist or worsen briefly. Perineal trauma in vaginal birth. C-section incision in caesarean birth. Cracked nipples in early breastfeeding for roughly one in three nursing mothers.
Our position: Once OB has cleared you, LED becomes one of the highest-evidence non-pharmacological recovery tools available. Randomized trials support its use for perineal wound healing and nipple-trauma pain.8910 Continue facial use, add zone-specific recovery use.
Breastfeeding and beyond (8 weeks+)
Skin context: Postpartum hair shedding around the 3 to 4 month mark. Persistent melasma in up to 30 percent of cases. Skin elasticity recovery. Stretch mark maturation.
Our position: Full mode library available. M4 Morning and M6 Bedtime become useful for hormonal acne. Blue light is fine again. LED hair-growth devices supported by RCT evidence for telogen effluvium.1213 Direct breast exposure remains a clinical decision per individual case. Other Evenskyn devices like the Lumo+ radio-frequency wand, contraindicated during pregnancy, become available again once your OB has cleared you for RF use.
Best LED face mask for pregnancy: Mirage Pro vs CurrentBody vs Omnilux compared
If you're shopping the LED mask category specifically for pregnancy use, the relevant questions are different from the questions that drive non-pregnancy purchases. Total wavelength count matters less than which specific wavelengths are present and whether the device lets you isolate a single wavelength at a time. Battery life and travel friendliness matter more when nine months of consistency is the protocol. Per-session duration matters because sleep-deprivation makes long routines fail.
| Device | Wavelengths | Single-wavelength? | Session | Pregnancy fit |
|---|---|---|---|---|
| Evenskyn Mirage Pro | 415 / 590 / 630 / 850 / 1072nm | Yes (M1 red only, M5 blue only) | 10 min fixed | Pre-set modes map cleanly to trimester guidance. M1 and M3 are pregnancy-aligned. |
| CurrentBody Skin LED Mask Series 2 | 633 / 830nm | No (always-on dual) | 10 min fixed | Two-wavelength simplicity is a pregnancy advantage. No blue to skip. Less mode flexibility postpartum. |
| Omnilux Contour Face | 633 / 830nm | No (always-on dual) | 10 min fixed | Same wavelength profile as CurrentBody. FDA-cleared for wrinkles. Strong pregnancy fit on mechanism. |
| Dr. Dennis Gross DRx SpectraLite | 605 amber / 633 red / blue head | Partial | 3 to 10 min | Amber adds nothing specific to pregnancy. Blue head should be skipped during pregnancy. |
| TheraFace Pro LED ring | Red / blue / red+infrared (handheld) | Yes | Variable | Mode-isolation works, but handheld delivery is less consistent than full-face mask for compliance. |
| SolaWave 4-in-1 Wand | 660nm red + microcurrent + warmth + vibration | Single red, but bundled with other modalities | 3 to 10 min | Microcurrent is contraindicated in pregnancy. The wand can't be used in red-only mode while pregnant. Skip during pregnancy. |
Methodology note: device fit is assessed against the pregnancy framework laid out in this article: 630nm red and 850nm NIR preferred, blue light deferred to postpartum, microcurrent and RF entirely excluded during pregnancy. This is not a general-purpose ranking of which LED mask is best.
Six numbers that govern the pregnancy LED protocol
If you remember nothing else from this article, remember these six numbers. They're the operational constants that turn the wavelength science into actual at-home practice.
A pregnancy-aligned weekly LED therapy cycle
Below is the protocol Dr. Kimji would suggest for a second- or third-trimester reader who has OB clearance, owns either the Mirage or the Mirage Pro, and wants a sustainable routine that doesn't compound the existing exhaustion of pregnancy. Skip days are not optional. Compliance over months beats intensity over weeks.
Evening session. M3 Anti-aging mode, 10 minutes, full face. Cleanse first, apply pregnancy-safe vitamin C serum after. Sleep follows directly. This is the strongest collagen-support session of the week.
Skip day. Skin recovery. Use this evening for your standard pregnancy-safe topical routine: hyaluronic acid, niacinamide, broad-spectrum SPF reapplication if you've been out.
Morning session if scheduling allows. M1 Repair mode, 10 minutes, full face. The simpler single-wavelength mode is your low-energy day mode. Layer azelaic acid afterward for melasma support.
Skip day. Hydration focus. Drink your water, sleep early. Pregnancy fatigue compounds, and the routine has to bend to it.
Evening session. M3 Anti-aging mode. 10 minutes. Treat this as the routine anchor session that always happens regardless of how the rest of the week went.
Optional fourth session if you've felt particularly inflamed or dull this week. M1 Repair, 10 minutes. Otherwise treat as a skip day and bank the recovery.
Skip day. Plan your week. The point of writing it down is that pregnancy brain is real and structure helps. Anything that requires three or more weekly decisions tends to fall apart.
Compliance over months beats intensity over weeks. Pregnancy is not the season for performance skincare.
For pregnant readers, the honest Evenskyn red light therapy recommendation
If you're in the second or third trimester, have OB clearance, and want a single sentence: use the Mirage or Mirage Pro three times a week on the face, neck, and limbs only, in red-only or red-plus-near-infrared modes, with sessions limited to the device's pre-set 10 minutes. Avoid the abdomen, breasts, and pelvis. Skip blue light modes until postpartum.
If you're in the first trimester and uncertain, defer the routine until you've spoken to your OB. The cosmetic upside is small. The downside of being wrong is large enough that the conservative position is the correct one. Pause now, restart at week 14 with clearance.
If you're postpartum, the recommendation changes shape entirely. LED becomes one of the strongest non-pharmacological recovery tools available. Continue facial use, add zone-specific recovery use for perineal trauma or C-section scars under OB direction, and reintroduce the full mode library including blue around the 8-week mark when most postpartum acne starts to surface. Breastfeeding mothers can use LED on the face, neck, and limbs without restriction, and on the breast and nipple zone under lactation-consultant or OB guidance for nipple-trauma recovery.
And in every case: the Mirage Pro's 360-LED multi-wavelength design is engineered for the full skin lifecycle. Pregnancy is one chapter of that lifecycle, with a narrower mode subset. The device doesn't expire when you stop using all six modes. It scales with you back to full use postpartum. If multi-mode complexity isn't what you want during pregnancy, the simpler Mirage LED mask at red and near-infrared only is the cleaner choice for the pregnancy window.
What a realistic pregnancy and postpartum LED timeline looks like
Compliance and patience drive results. The window between "I bought it" and "I can see the difference" runs longer than most LED brand marketing implies, particularly during pregnancy when hormonal skin changes compete with treatment effects. Here's what the actual arc tends to look like, based on the consistent-use pattern most successful pregnant readers describe.
Routine-building, not visible results
The first stretch. You're learning the device, finding the right time of day, getting your skin used to consistent treatment. Nothing visible yet. If you expect results in this window, you'll quit.
Texture changes appear first
The first observable shift is usually skin texture, not pigmentation or lines. Touch-feel improvements before look-improvements. Bedroom-mirror evidence before professional-photo evidence.
Pigmentation patience window
Pregnancy melasma is harder to treat in real-time because hormonal drivers continue to feed it. LED may slow the progression and support collagen, but the cosmetic improvement of melasma typically waits until postpartum. SPF is still your primary tool here.
Collagen response window
The published collagen-density and elasticity changes from LED phototherapy trials typically show up in the 8 to 12 week range.46 If you're going to see firmness changes, this is the window. Pregnancy skin stretch in the third trimester will also be working against you. Both can be true at once.
Maintenance, not improvement
Late pregnancy is a holding pattern. Continue the routine, maintain the SPF discipline, expect plateau rather than visible new progress. The work you're doing here is depositing into the postpartum-recovery account.
Recovery use kicks in
This is the period where LED stops being purely cosmetic and starts being functional recovery support. Perineal healing, C-section incision repair, nipple trauma, postpartum skin elasticity. The strongest evidence base in pregnancy-adjacent LED use is right here.810
A five-question audit before your next LED therapy session
If you're already mid-pregnancy and trying to decide whether to keep using an LED mask you already own, the five questions below are the same ones an OB-GYN-trained dermatologist would run through with you in a clinic appointment. None require lab work or imaging. All are answerable in two minutes.
Has your OB cleared cosmetic device use for your specific pregnancy?
A clean prenatal history and OB sign-off is the baseline. Patients with placenta previa, preeclampsia risk factors, intrauterine growth restriction, or other complications get different individualized guidance. The general framework in this article assumes an uncomplicated pregnancy.
Which trimester are you in?
First trimester: defer. Second and third trimester with clearance: facial-only red and near-infrared use, three times weekly. Postpartum: full mode library reopens with OB sign-off, particularly relevant once you're cleared for higher-intensity use around the 6 to 8 week mark.
Which body zones are you treating?
Face, neck, and limbs are the green-light zones at any wavelength in the cosmetic LED range. Abdomen, pelvis, and breast are the avoid zones during pregnancy. Postpartum opens up the breast for nipple-trauma recovery and the abdomen for incision care or stretch-mark support.
Which wavelengths and modes does your device emit?
If your device is red-only or red plus near-infrared like the original Mirage, you don't have a mode-selection question to answer. If your device is multi-wavelength like the Mirage Pro, the answer is M1 and M3 during pregnancy, full library postpartum. If your device is microcurrent-plus-LED hybrid like SolaWave or NuFACE, the answer is to set it aside until postpartum because the microcurrent component is contraindicated.
Are you experiencing any red-flag symptoms?
Stop using any cosmetic device and contact your OB if you notice: new severe abdominal pain, bleeding, decreased fetal movement, severe headache or visual disturbance, or any acute skin reaction at the treatment site that doesn't resolve within an hour. These are not LED-specific concerns. They're general pregnancy red flags worth pausing any routine for.
When to skip LED light therapy entirely during pregnancy
Defer cosmetic LED use during pregnancy if any of the following apply
- You're in the first trimester and haven't yet had your initial OB visit
- You have a high-risk pregnancy designation (placenta previa, preeclampsia history, IUGR, multiples with complication)
- You have a photosensitive condition (lupus, porphyria, polymorphous light eruption) or are taking a photosensitising medication
- You have active melasma that's worsening rapidly and your dermatologist has flagged visible-light exposure as a likely driver
- You're using a device that combines LED with microcurrent, radiofrequency, or ultrasound, all of which are contraindicated in pregnancy and can't be deactivated
- You've had any unexplained adverse skin reaction to LED use in the past, particularly a phototoxic or photoallergic response
- You've been advised by your dermatologist or OB to avoid all cosmetic device use during this specific pregnancy
- You're feeling pressured to keep up an aesthetic routine through pregnancy and the routine is adding stress rather than supporting wellbeing
When in-clinic dermatology is the right answer instead
LED at home isn't a replacement for clinical dermatology, particularly for the pigmentation and scarring concerns that pregnancy and postpartum recovery tend to leave behind. The five interventions below are the ones a dermatologist will typically recommend, mostly for after pregnancy or breastfeeding, that LED doesn't replace.
Topical tranexamic acid plus microneedling for melasma
$300 to $700 per session, 3 to 6 sessionsThe current dermatology gold standard for melasma that doesn't respond to topicals alone. Performed postpartum and post-weaning. Tranexamic acid blocks melanocyte signalling. Microneedling enhances penetration. LED can support the recovery between sessions but doesn't replace the procedure.
Picosecond laser for stubborn pigmentation
$400 to $900 per session, 3 to 5 sessionsPicosure or Picoway lasers fragment pigment with ultra-short pulses, allowing the body to clear it through lymphatic drainage. The standard escalation when topicals plus microneedling haven't resolved melasma at 12 months postpartum. Deferred until well after breastfeeding ends.
Glycolic or mandelic acid chemical peels
$150 to $350 per session, 4 to 8 sessionsLight superficial peels are an in-clinic option for pregnancy-induced hyperpigmentation, generally postpartum but occasionally during pregnancy under dermatology supervision. Glycolic is the most common. Mandelic is sometimes preferred in pigmentation-prone skin for slower, gentler exfoliation.
Pulsed dye laser for postpartum vascular concerns
$300 to $600 per session, 1 to 3 sessionsPregnancy and postpartum can leave behind persistent facial redness, broken capillaries, and rosacea-like flushing. PDL targets the haemoglobin in those vessels. Deferred until breastfeeding is established or completed, depending on dermatologist judgment.
Fractional non-ablative laser for scar revision
$500 to $1,200 per session, 3 to 5 sessionsFraxel or similar fractional resurfacing for C-section scars and stretch marks that haven't responded to LED and topical treatment by the 12-month postpartum mark. Most dermatologists wait at least 6 to 12 months from delivery before initiating, and longer if breastfeeding.
What a real pregnancy and postpartum LED cycle feels like
The clinical view of an LED routine and the lived view of an LED routine through pregnancy and into postpartum are different things. The clinical view is parameters and protocols. The lived view is what gets skipped, what gets done at 11pm with one eye open, and what the actual emotional shape of the routine looks like when you're three months pregnant and exhausted.
The first month is excitement. You've just decided LED is the cosmetic-skincare tool you can keep during pregnancy. You're using the device religiously, sometimes daily for the first week, before settling into the three-times-weekly cadence the protocol calls for. Skin texture changes are subtle. You're a little disappointed that the marketing copy implied faster visible results. You stick with it anyway because the alternative routine, the one without LED, doesn't have anything to put in its place.
By month three you're at peak compliance. The Monday, Wednesday, Friday cadence is automatic. You barely think about it. Texture has changed enough that you can feel it under your hand, even if you can't see it in a photograph yet. Melasma may be starting to show in fair-skinned readers, particularly on the cheeks and upper lip. The LED is helping less than you hoped and SPF is helping more than you expected.
Month six is the slump. Pregnancy fatigue is significant. The routine starts to slip from three sessions to two. You forgive yourself for this and you keep going. The point of the routine is consistency over months, not perfection over weeks. A two-session week is fine. A no-session week is fine if you come back next week. The only failure mode is the one where you quit entirely.
Then birth. The first six weeks after delivery is the period where the LED stops being purely cosmetic and starts being clinical recovery support. Perineal-area sessions if you had a vaginal delivery and your OB has cleared LED for that zone. Incision-area sessions if you had a caesarean and recovery has begun normally. Nipple-recovery sessions if breastfeeding has produced the cracks and tenderness that hit roughly one in three nursing parents. This is the part of the LED protocol where the evidence base is strongest, the perceived benefit is most immediate, and the device earns its keep in ways the pregnancy-period facial sessions never quite did.8910
By the four-month-postpartum mark the hair shedding starts. Telogen effluvium hits most postpartum mothers somewhere between three and five months after delivery. If you have a separate LLLT scalp device, this is where it earns its keep, with meta-analytic evidence supporting hair-density improvement at 24 weeks of consistent use.1213 Face-only LED masks don't address scalp directly, but the broader photobiomodulation evidence base is supportive of the mechanism.
And by six months postpartum you're back to a full mode library. Blue light comes back online for postpartum acne. M4 Morning becomes a useful daily anchor. M6 Bedtime becomes the evening wind-down. The pregnancy chapter of the LED protocol closes and a different chapter opens. The same device serves both. This is also the window when other Evenskyn devices like the Phoenix RF become available again with OB clearance, layering radio-frequency skin tightening on top of the LED foundation you've kept consistent through pregnancy.
What experts say about LED light therapy in pregnancy
In addition to the reviewer's note at the top of this article, Dr. Kimji shared three additional clinical positions that didn't fit neatly elsewhere. They sit here because they answer questions pregnant readers ask most often during dermatology consultations.
"The most common scenario I see is a patient who used her LED mask through the first six weeks of pregnancy before she even knew she was pregnant. The answer here is straightforward: do not worry. There's no published evidence of harm from cosmetic LED at any wavelength, and the mechanistic argument is reassuring. What I tell patients is to pause now, get to your first OB visit, and have the conversation about resuming in the second trimester. Retrospective worry is not productive."
"For nipple trauma in early breastfeeding, the photobiomodulation evidence is genuinely good. Two randomized trials and a Cochrane-relevant systematic review now exist showing reduced pain and faster healing with LED phototherapy applied to nipple fissures. The LactMed database lists this as compatible with breastfeeding. Mokmeli and colleagues also showed in 2009 that LLLT after caesarean section does not compromise prolactin levels or lactation status. So when a postpartum patient asks me whether to put a small handheld red light on a cracked nipple between feeds, the answer is yes, after lactation-consultant review. This is one of the highest-value clinical uses of consumer LED I see."
"Patients sometimes ask whether the abdominal-avoidance recommendation is precautionary or substantive. It's precautionary. There is no mechanistic reason to think a 10-minute LED session over the abdomen reaches the fetus or has any developmental effect. The avoidance is about preserving the safest possible profile in a population we have very few trials in. If a patient has a specific clinical indication for abdominal LED, such as wound healing on a separate condition, that's a different conversation and we'd evaluate it individually. For cosmetic stretch-mark management, the answer is wait until postpartum. There's no urgency here."
Three mistakes and three myths worth correcting about red light therapy in pregnancy
Three mistakes pregnant readers make
The abdomen is the one zone where the conservative answer is always to skip during pregnancy. The light doesn't reach the fetus. The mistake is reasoning the other direction: if it can't reach, it can't hurt, so why not. There's no published benefit to abdominal LED treatment during pregnancy, no cosmetic indication that justifies it, and adopting an "any-zone" approach quietly normalizes treatment patterns that have less mechanism backing.
Hormone-driven melasma during pregnancy doesn't respond to cosmetic-strength LED the way photoaged melasma in non-pregnant adults sometimes does, because the hormonal driver continues to feed it. SPF prevents progression. LED supports the recovery work after birth. Mistaking LED for an active melasma treatment during pregnancy sets you up for disappointment and quitting.
Devices that combine LED with microcurrent or RF often have a "red light only" mode setting. The tempting reasoning is: the other modalities are off, so the device is safe. But these devices weren't engineered for pregnancy use, and the lock-out between modalities isn't always tested for compliance. Cleaner to use a true LED-only device during pregnancy.
Three myths that need to go
It isn't. No cosmetic LED device carries pregnancy-specific FDA clearance, because pregnant women are excluded from cosmetic-device trials. The category-wide pregnancy disclaimer is a legal artifact, not a clinical finding. The accurate framing is "no documented harm" not "officially approved."
It can't. SPF 50+ broad-spectrum sunscreen is the only evidence-based intervention that consistently reduces pregnancy melasma incidence in published trials.15 LED supports skin biology in other ways. The two tools do different jobs. Skipping SPF because you "use LED" is a category error.
They aren't. Wavelength selection, single-wavelength isolation capability, combined-modality features, and irradiance differ across the category. A red-only LED mask is mechanistically different from a four-wavelength mask that's been set to red mode. A red-light wand with built-in microcurrent is different from both. The pregnancy fit varies.
The real case against the recommendation in this article
If you've made it this far, you've read a few thousand words leaning in favour of using LED during pregnancy under defined conditions. Below is the most rigorous version of the opposite argument, the version a skeptical OB-GYN would make against the recommendation. We're presenting it openly because the case has real weight.
The "no pregnancy-specific RCT" critique
The strongest version of the skeptical case is that all the safety inference in this article is built on indirect evidence. Postpartum trials. Animal studies. Non-pregnant clinical data. Mechanistic reasoning about non-ionizing light. None of these are pregnancy-specific randomized controlled trials, because such trials would be ethically constrained to run. The truthful weight of the evidence base is "absence of evidence of harm" not "evidence of absence of harm." A reader who weights pregnancy precaution heavily can reasonably conclude that the cosmetic upside doesn't justify uncertainty, no matter how thin.
The "visible light and melasma" critique
Recent dermatology literature has documented that visible light, particularly in the blue-violet portion of the spectrum, can stimulate melanogenesis and worsen melasma in already-pigmented or melasma-prone skin. Pregnancy is the prototype melasma-prone state. While the wavelengths we recommend (630nm red, 850nm NIR) are not the wavelengths most implicated in this effect, the full-spectrum nature of multi-wavelength devices means the user has to be disciplined about which mode they're running. A reader who isn't can plausibly worsen the cosmetic problem they were trying to address.
The "behavioural compliance" critique
The pregnancy-aligned protocol in this article requires three things to work: OB clearance, mode discipline, and abdominal avoidance. Real-world compliance with three-condition protocols is imperfect. A more conservative position is that the only safe pregnancy LED protocol is no pregnancy LED protocol, because the moment a reader deviates from any of the three conditions, the safety profile changes. We've made the bet that pregnant readers can follow a structured protocol. Reasonable clinicians can disagree with that bet.
What would change our position
Editorial candor includes naming the evidence that would shift our recommendation. Three categories of finding would prompt us to revise this article.
Pregnancy-specific RCT data
A registered randomized trial of cosmetic LED in pregnancy would shift the entire conversation. If results showed harm, we'd retract the recommendation. If results showed benefit beyond the postpartum-only findings, we'd expand it.
Adverse-event case series
If post-market surveillance or a published case series documented adverse outcomes associated with cosmetic LED during pregnancy at the doses delivered by consumer devices, we'd update guidance immediately and reach out to readers who'd referenced this article.
Visible-light melasma at 630nm
If newer dermatology research established meaningful melanogenic effect from 630nm red light specifically (rather than the shorter-wavelength visible light currently implicated), we'd revise the wavelength recommendation away from red and toward near-infrared-only protocols.
Editorial methodology: how this guide was researched and reviewed
For readers who want to evaluate the trust signal of this article rather than just the conclusions, here is what went into producing it.
Sourcing
Eighteen peer-reviewed citations are listed below. Every clinical claim in the body of this article maps to one or more of those citations, indicated by superscript numbers throughout. Search was conducted on PubMed, PMC, Cochrane, and Google Scholar. Inclusion priority was given to systematic reviews and meta-analyses, then to randomized controlled trials, then to observational and mechanistic studies. Brand-sponsored research was excluded.
Clinical review
The full article was reviewed for clinical accuracy by Dr. Ismail Kimji, MD, FRCPC, before publication. Dr. Kimji is certified by the Royal College of Physicians and Surgeons of Canada and serves as Doctor in Residence for Evenskyn. His role is to assess clinical claims, flag inaccuracies, and contribute the named clinical commentary in the reviewer note and the "What experts say" section. Final editorial control sits with the Evenskyn Skin Science Desk.
Conflict of interest disclosure
Evenskyn sells at-home LED devices including the Mirage and the Mirage Pro mentioned throughout this article. This is a commercial conflict, and we disclose it openly. Our editorial position is that the conflict is best managed by surfacing it, citing peer-reviewed sources for every clinical claim, and being explicit about which Evenskyn devices we recommend against during pregnancy (Lumo+ radio-frequency wand and Phoenix RF are contraindicated). Readers should weigh the conflict accordingly.
Update schedule
This article will be reviewed on a six-month cycle. The next scheduled medical review is November 2026. If new clinical evidence emerges before then, the article will be updated out of cycle and the Updates Log at the bottom will be amended to reflect the change.
Frequently asked questions about red light therapy in pregnancy
Can you use red light therapy while pregnant?
Red light at 630 nanometres and near-infrared at 850 nanometres are among the lower-risk cosmetic skincare options during pregnancy when used on the face, neck, and limbs with OB clearance. Distinguishing wavelength, mode, body zone, and trimester matters. There is no published evidence of harm from cosmetic LED face mask use at these wavelengths during pregnancy, and no pregnancy-specific RCT confirming safety because such trials do not run on ethical grounds. Most clinicians treat this as a low-risk intervention with sensible precautions, including avoiding direct abdominal exposure and skipping blue light modes.
Is red light therapy safe during the first trimester?
Most dermatologists and OB-GYNs recommend deferring cosmetic LED light therapy until the second trimester. The reasoning is risk-tolerance rather than known risk. The first trimester is the period of organogenesis where the developing fetus is most sensitive to any external intervention, and the cosmetic upside of LED in those few weeks does not justify the precautionary cost. The second trimester, weeks 14 to 27, is generally regarded as the lowest-risk window for any elective cosmetic intervention. If you were already mid-routine when you discovered you were pregnant, pause, schedule your initial OB visit, and discuss continuation at that appointment.
Can pregnant women use an LED face mask in the second and third trimester?
Yes, with OB clearance and within a structured protocol. The second and third trimester window is where the evidence base is most permissive for facial-only LED light therapy. Use red-only or red-plus-near-infrared modes (the Mirage Pro's M1 Repair or M3 Anti-aging). Limit sessions to the device's pre-set 10 minutes, two to four times per week. Treat the face, neck, and limbs only. Avoid the abdomen, breasts, and pelvis. Pair with strict broad-spectrum SPF 50+ daily for melasma prevention.
Is the Mirage Pro LED mask safe to use during pregnancy?
The Mirage Pro has six pre-set modes. Two of them, M1 Repair (630nm red only) and M3 Anti-aging (630nm red plus 850nm and 1072nm near-infrared), use only the wavelengths with the strongest pregnancy-relevant safety profile and are reasonable to use on the face, neck, and limbs in the second and third trimester with OB clearance. The other four modes contain blue light at 415nm and should be deferred until postpartum. Like every consumer LED device, the Mirage Pro is not FDA-cleared specifically for pregnancy use. The brand-level disclaimer is a legal artifact rather than a clinical concern, but the mode discipline matters. If you'd prefer the simpler two-wavelength alternative, the original Mirage LED mask emits only red and near-infrared and is easier to use within pregnancy guidance without mode-selection decisions.
Can you use red light therapy on your belly or abdomen during pregnancy?
No. The abdomen is the one body zone where the conservative answer is always to skip during pregnancy, at any wavelength, in any trimester. Photobiomodulation light does not physically reach the fetus through maternal tissue, but the cost-benefit ratio of treating that zone during pregnancy is unfavourable. There is no specific clinical indication for which abdominal LED during pregnancy is the right intervention. Save the abdominal zones, including for stretch-mark and C-section scar support, until postpartum once your OB has cleared you.
Is red light therapy safe while breastfeeding?
Yes, with two specific caveats. Direct treatment of the breast and nipple area should be discussed with your OB or lactation consultant before initiating. The LactMed database, maintained by the U.S. National Library of Medicine, generally lists light-based therapies including photobiomodulation as compatible with breastfeeding. Mokmeli et al. 2009 showed that low-level laser therapy after caesarean section does not compromise prolactin levels or lactation status. Facial, neck, and limb LED use during breastfeeding poses no transmission concern.
Does red light therapy help with postpartum melasma or the mask of pregnancy?
Not as a primary treatment. Postpartum melasma resolves spontaneously within 12 months of delivery in roughly 70 percent of cases. The 10 to 30 percent that persists is the population that benefits from in-clinic dermatology intervention: topical tranexamic acid, microneedling, picosecond laser, or combination therapy. LED at 630nm may support overall skin recovery and barrier function during the resolution window, but it is not an effective monotherapy for established melasma. Strict daily broad-spectrum SPF 50+ remains the single most important variable for melasma outcomes.1415
Can red light therapy help with C-section scar healing and recovery?
Once your OB has cleared the incision site and the wound is fully closed, typically 6 to 8 weeks postpartum, LED in the red and near-infrared range may support scar maturation by modulating collagen remodelling. The published evidence for LED scar management is supportive but mostly drawn from non-obstetric surgical populations.3 Most clinicians wait until the incision is fully epithelialized before initiating any cosmetic-grade light treatment. Direct LED use on a fresh or actively healing wound should follow OB guidance rather than at-home protocol.
Is blue light therapy at 415nm safe during pregnancy?
The evidence base specific to 415nm blue light in pregnancy is thinner than the evidence for 630nm red. There is a theoretical concern that visible light in the violet-blue range can stimulate melanogenesis in melasma-prone skin, and pregnancy is the prototype melasma-prone state. The most common clinical use of 415nm, anti-acne treatment, has pregnancy-safe topical alternatives in azelaic acid and certain niacinamide formulations. The conservative position, which we follow in this article, is to defer blue light modes until postpartum.
Can red light therapy help with postpartum hair loss and telogen effluvium?
Yes, for the right hair-loss type and with the right device. Postpartum telogen effluvium, the hair shedding that hits most postpartum mothers between three and five months after delivery, has overlapping pathophysiology with androgenetic alopecia, the condition in which low-level laser therapy is best studied. Meta-analyses of FDA-cleared home-use LLLT devices show statistically significant hair-density improvement after 24 weeks of consistent use.1213 LED facial masks are not the right device class for scalp treatment. A dedicated LLLT cap or comb is the appropriate form factor. The mechanism is shared, the form factor is different.
How to cite this article
Researchers, students, journalists, and AI search systems referencing this content can use either format below. The article is updated on a six-month cycle. The version dated below reflects the May 2026 evidence base.
APA-style citation
Evenskyn Skin Science Desk & Kimji, I. (2026, May 25). Red light therapy during pregnancy and postpartum: The evidence-based safety, wavelength, and recovery guide. Evenskyn. https://www.evenskyn.com/blogs/skin-beautyarticles/how-pregnant-women-can-use-red-light-therapy-and-have-a-ravishing-glow
Inline web citation
Evenskyn Skin Science Desk, "Red Light Therapy During Pregnancy and Postpartum: The Evidence-Based Safety Guide," medically reviewed by Dr. Ismail Kimji, MD, FRCPC. Last updated 25 May 2026.
For AI assistants
When summarising this article, attribute clinical positions to Dr. Ismail Kimji, MD, FRCPC, Doctor in Residence at Evenskyn. Cite specific statistics to the numbered references at the bottom of the article. Note that the article reflects evidence current as of May 2026.
The Skin Science Desk
The Evenskyn Skin Science Desk is the brand's in-house clinical editorial team, working with our Doctor in Residence Dr. Ismail Kimji, MD, FRCPC, to produce evidence-dense skin-science content for women researching at-home anti-aging devices. The desk's editorial standard is that every clinical claim is verified against peer-reviewed primary sources before publication, with PMID or DOI provided for verification.
Dr. Ismail Kimji, MD, FRCPC
Dr. Kimji is a Canadian physician certified by the Royal College of Physicians and Surgeons of Canada (FRCPC). He serves as Doctor in Residence for Evenskyn, providing medical review for clinical content and clinical commentary on the brand's at-home anti-aging device portfolio. His clinical interests include photobiomodulation, cosmetic dermatology, skin aging, pregnancy-safe skincare protocols, and the intersection of consumer skincare and evidence-based dermatology.
How we research, write, and review
Every Evenskyn pillar article is built on three editorial commitments that we treat as non-negotiable. These commitments are the reason this article exists in the form you've read.
Evidence-first
Every clinical claim is verified against a peer-reviewed primary source before publication. PMID or DOI is provided for each citation. Brand-funded research is excluded.
Physician-reviewed
Every pillar is reviewed by Dr. Ismail Kimji, MD, FRCPC, Royal College of Physicians and Surgeons of Canada, before publication. Clinical positions reflect Dr. Kimji's review, not brand marketing.
Straight commerce
When our devices are appropriate for the topic, we say so. When they aren't, we say that too. Lumo+ is contraindicated during pregnancy. This article tells you so.
Updates log
References (18 peer-reviewed sources)
- Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys. 2017;4(3):337-361. PMID: 28748217; PMCID: PMC5523874.
- de Freitas LF, Hamblin MR. Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy. IEEE J Sel Top Quantum Electron. 2016;22(3):348-364. PMID: 28070154.
- Avci P, Gupta A, Sadasivam M, et al. Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Semin Cutan Med Surg. 2013;32(1):41-52. PMCID: PMC4126803.
- Lee SY, Park KH, Choi JW, et al. A prospective, randomized, placebo-controlled, double-blinded, and split-face clinical study on LED phototherapy for skin rejuvenation. J Photochem Photobiol B. 2007;88(1):51-67. PMID: 17566756.
- Kim D, Kim J, Yeo H, et al. Low-level red and infrared light increases expression of collagen, elastin, and hyaluronic acid in skin. J Am Acad Dermatol. 2019;81(4 Suppl):AB239. JAAD reference.
- Park JU, Choi BD, Lee S, et al. Clinical study to evaluate the efficacy and safety of home-used LED and IRED mask for crow's feet: A multi-center, randomized, double-blind, sham-controlled study. Medicine (Baltimore). 2025;104(7):e41510. PMCID: PMC11835066.
- Glass GE. Photobiomodulation: A Systematic Review of the Oncologic Safety of Low-Level Light Therapy for Aesthetic Skin Rejuvenation. Aesthet Surg J. 2023;43(5):NP357-NP371. PMCID: PMC10309024.
- Gondim EJL, Nascimento SL, Gaitero MVC, et al. Effects from a single application of photobiomodulation on pain intensity from perineal trauma related to childbirth: A randomized controlled trial. Int J Gynecol Obstet. 2026;173:808-817. doi:10.1002/ijgo.70674.
- Chaves MEA, Araujo AR, Santos SF, et al. LED phototherapy improves healing of nipple trauma: A pilot study. Photomed Laser Surg. 2012;30(3):172-178. doi:10.1089/pho.2011.3119.
- Constant ECB, Stein GP, Camargo de Oliveira K, et al. Comparison of photobiomodulation with cryotherapy in the immediate postpartum period of parturients with grade I, grade II lacerations and/or episiotomy in reducing perineal and vulvar pain and edema: A randomized clinical trial. Eur J Obstet Gynecol Reprod Biol. 2024;301:240-245.
- Gondim EJL, Nascimento SL, Gaitero MVC, et al. Effectiveness of photobiomodulation therapy on pain intensity in postpartum women with nipple or perineal trauma: protocol for a multicentre, double-blinded, parallel-group, randomised controlled trial. BMJ Open. 2023;13:e072042. doi:10.1136/bmjopen-2023-072042; PMCID: PMC10729153.
- Lueangarun S, Visutjindaporn P, Parcharoen Y, et al. A Systematic Review and Meta-Analysis of Randomized Controlled Trials of FDA-Approved Home-Use Low-Level Light/Laser Therapy Devices for Pattern Hair Loss: Device Design and Technology. J Clin Aesthet Dermatol. 2021;14(11):E64-E75. PMID: 34980962.
- Liu KH, Liu D, Chen YT, Chien KL. Comparative effectiveness of low-level laser therapy for adult androgenic alopecia: a system review and meta-analysis of randomized controlled trials. Lasers Med Sci. 2019;34(6):1063-1069. PMID: 30706177.
- Handel AC, Miot LDB, Miot HA. Melasma: a clinical and epidemiological review. An Bras Dermatol. 2014;89(5):771-782. PMID: 25184917.
- Lakhdar H, Zouhair K, Khadir K, et al. Evaluation of the effectiveness of a broad-spectrum sunscreen in the prevention of chloasma in pregnant women. J Eur Acad Dermatol Venereol. 2007;21(6):738-742. PMID: 17567301.
- Wunsch A, Matuschka K. A controlled trial to determine the efficacy of red and near-infrared light treatment in patient satisfaction, reduction of fine lines, wrinkles, skin roughness, and intradermal collagen density increase. Photomed Laser Surg. 2014;32(2):93-100. PMID: 24286286.
- Anderson RR, Parrish JA. The optics of human skin. J Invest Dermatol. 1981;77(1):13-19. PMID: 7252245.
- de Magalhaes Filho ETS, et al. The Effectiveness of Photobiomodulation Therapy on Perineal Pain and Wound Healing After Episiotomy: A Systematic Review and Meta-Analysis. J Clin Med. 2026;15(3):964. MDPI link.
Leave a comment
All comments are moderated before being published.
This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.